The EU had previously approved two vaccines for protecting ... "This approval of the first mRNA vaccine against RSV clearly shows the importance of innovation when it comes to protecting the ...
The company's vaccine consists of an mRNA sequence encoding a stabilized prefusion F glycoprotein.
GSK’s Arexvy has become the first vaccine for respiratory syncytial virus (RSV) to be approved in the EU, getting the nod from the European Commission for use in older adults aged 60 or over.
A UPMC pulmonologist talks about the symptoms, explains who is most at risk for a severe infection, and tells us how ...
The European Commission on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults -- the first time the bloc ... "Vaccination saves lives," the EU's commissioner ...